Nature Reviews Drug Discovery
Volume 21 Issue 1, January 2022
Comment | 29 July 2021
Therapeutic genome editing: regulatory horizons
An increasing number of genome-editing technologies are being developed. Here, we highlight some of the key issues for future therapies using these technologies from a regulatory perspective.
Philip A. Hines, Eleonora Agricola, Ralf Herold